Articles |
From the Departments of Internal Medicine and Pathology II, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
Correspondence to Dr Xi Ming Yuan, Clinical Research Center, Faculty of Health Sciences, Linköping University, S-582 25 Linköping, Sweden.
| Abstract |
|---|
|
|
|---|
Key Words: LDL foam cells iron exocytosis oxygen radicals
| Introduction |
|---|
|
|
|---|
Although this chain of events is generally accepted, there are many unsolved questions concerning several fundamental parts of the process, eg, how and where the LDL particles become oxidized. Most authors favor the opinion that LDL oxidation occurs in the arterial intima under the influence of oxygen-derived reactive metabolites and the catalytic activity of transition metals in a reduced state.2 3
It has been convincingly shown that both copper and iron in reduced form can oxidize LDL into a form that is recognized by the macrophage scavenger receptor.4 5 This type of LDL oxidation is further stimulated by a variety of cell types, eg, monocytes, macrophages, smooth muscle cells, and endothelial cells, which are all known to produce superoxide anion radicals and hydrogen peroxide.1 2
Both copper and iron are present in atheromatous lesions, but neither the origin of these metals nor their relation to macrophages and smooth muscle cells under the formation of early atherosclerotic lesions has been determined.6 7 8
In vitro oxidation of LDL is often accomplished by exposing it in serum-free cell culture medium to reduced transition metals in nanomole or micromole per liter concentrations, eg, Ham's F10 medium, which contains about 3 µmol/L iron. However, in vivo the two most abundant catalytically active transition metals, iron and copper, are unlikely to exist in free form in plasma or interstitial fluids.6
In this study we suggest that migrating HMDMs that temporarily reside in vessel walls may, under certain conditions, eg, as a result of phagocytotic uptake of cellular debris or erythrocytes rich in iron-containing metalloproteins, for a limited time contain secondary lysosomes with a high concentration of iron. Such cells may, in a microenvironment, expose LDL to a locally high concentration of iron in a catalytically active form due to exocytosis of lysosomal contents and, moreover, to superoxide, hydrogen peroxide, and hydroxyl radicals (as a consequence of Fenton chemistry). We here present experimental support for this hypothesis by using an in vitro model system of HMDMs exposed in culture to simple iron compounds and Hb.
| Methods |
|---|
|
|
|---|
Lipoprotein Preparation
LDL (1.025<d<1.050 g/mL) was freshly isolated by
sequential ultracentrifugation9 from
sera of normolipidemic donors who had fasted overnight. LDL was
prepared in the presence of EDTA (1.4 mg/mL) to inhibit lipid
peroxidation. LDL was finally dialyzed under nitrogen against 0.01
mol/L phosphate-buffered saline (0.16 mol/L NaCl), pH 7.4, for 24 hours
at 4°C before incubation with HMDMs.
Isolation and Culture of HMDMs
Mixed mononuclear cells were separated from the buffy coat of
fresh type A Rh+ donor blood by using the density-gradient
centrifugation method of Böyum.10
The buffy coat (20 mL) was layered over Ficoll-Paque (15 mL) and
centrifuged at 400g for 30 minutes at room
temperature. The mixed mononuclear cell band was removed by aspiration,
and the cells were washed three times and recentrifuged at
200g for 10 minutes in HBSS at room temperature to remove
platelets.
The platelet-free mononuclear cells were finally suspended in RPMI-1640 with 10% (vol/vol) FCS or homologous serum and plated in FCS-coated 35-mm tissue-culture Petri dishes (Costar) prepared according to the method of Kumagai et al.11 The cells were allowed to adhere for 3 hours at 37°C. Nonadherent cells were removed by gentle washing with complete growth medium.
This isolation procedure yielded monocyte preparations of more than 95% purity as judged by immunocytochemistry using the monoclonal antibody CD14. The monocytes matured to macrophages in 6 to 8 days. The medium was changed every 48 hours.
Experimental Method
After isolation the monocytes were cultured in RPMI-1640 medium
(claimed to be almost free of iron) with 10% FCS for 7 to 8 days in a
humidified 5% CO2air incubator at 37°C.
These cells were counted (5x106/mL) and seeded into multiwell plates (Costar) and exposed for 24 hours to iron compounds and Hb in complete culture medium. The medium was then removed, and the cells were rinsed twice in warm RPMI-1640. Fresh medium with LDL but without serum was then added to the wells. At the same time conditioned medium was collected from the iron- and Hb-exposed HMDM cultures. Iron content, superoxide production, TBARS, and LDL electrophoretic mobility were periodically measured during the incubation period. Cells on coverslips were removed from the wells 48 hours after the addition of medium with LDL, and autofluorescence (lipofuscin), neutral lipid, and phospholipid levels were measured.
Iron Content of Growth Media
After culture in complete growth media with
FeCl3, Fe-ADP, or Fe-EDTA (100 µmol/L iron) or Hb
(25 or 50 µg/mL) for 24 hours, the HMDMs were washed twice with
RPMI-1640. Cells were then exposed to LDL (100 µg/mL) for another 24
hours. The iron concentrations of the media were determined by atomic
absorption spectrophotometry (Z-8270 Polarized Zeeman, Hitachi) and
compared with concentrations in the media of control HMDMs.
Cell Viability
Lactic dehydrogenase activities in both the incubation media and
cellular pellet (homogenized in 0.1% Triton X-100) from
iron- and Hb-loaded HMDMs were determined at 37°C by measuring the
oxidation rate of lactate to pyruvate as the
NAD+/NADH conversion, which was monitored
spectrophotometrically at 340 nm.12 The viability of
experimental cells was also assayed morphologically and by a Trypan
Blue dye (0.1%) exclusion test.13 14
HMDM Superoxide Production
To examine the role of O2< ARRANGE="STAGGER">-
in the
experimental system, superoxide production was measured as
SOD-inhibitible reduction of ferric cytochrome c.15 HMDMs
were exposed for 24 hours to iron compounds or Hb in complete growth
media. The cells were then rinsed in HBSS and incubated under ordinary
culture conditions in RPMI-1640 (without phenol red and serum) together
with LDL (100 µg/mL) and cytochrome c (1 mg/mL) with (50 µg/mL) or
without SOD. Medium was removed for analysis of reduced
cytochrome c at regular intervals. The absorbance was read at 550 nm
against an RPMI-1640 blank. Reduction of cytochrome c was
calculated by using an extinction coefficient of 21.0
mmol/L · cm-1 and was expressed as the difference
between medium with and without SOD.16
LDL Oxidation (TBARS)
TBARS levels produced during LDL oxidation were determined
according to the method of Buege and Aust.17
Trichloroacetic acid (15% wt/vol) and TBA (0.375% wt/vol) were
dissolved in 0.25N hydrochloric acid. Butylated hydroxytoluene in
ethanol was added to the TBA reagent (final concentration, 0.01%).
Samples (0.5 mL) were added to 1 mL TBA reagent, and the mixed solution
was heated for 30 minutes at 98°C, cooled for 10 minutes, and
centrifuged at 1000g for 10 minutes. The absorbance
was determined at 532 nm in a Perkin-Elmer Lambda 2 UV/Vis Spectrometer
against a blank of TBA reagents added to RPMI-1640 medium without
phenol red. The TBARS concentration of the sample was calculated by
using an extinction coefficient of 156
mmol/L · cm-1.
Lipid Accumulation
Cells grown on coverslips were exposed to iron compounds and Hb
as described above, rinsed, and incubated in RPMI-1640 with LDL but
without phenol red and serum for 48 hours.
To evaluate the accumulation of lipids within HMDMs, a Nile red stock solution (100 µg/mL) in acetone was diluted 20 times with PBS and used to stain unfixed cells for 10 minutes at 37°C. The staining was followed by a rinse in PBS. After inverting the coverslips on excavated microculture slides in a drop of PBS, the stained cells were examined in an MPV-III Leitz fluorescence microscope integrated with an ABC 800 computer (Nokia AB) at two spectral settings: yellow-gold fluorescence, representing neutral lipids, was measured by using a filter combination (a 450- to 490-nm band-pass excitation filter, a 510-nm center wavelength chromatic beam splitter, and a 515-nm long-pass barrier filter) for fluorescein fluorescence; red fluorescence, representing phospholipids, was measured by using a filter combination (a 530- to 560-nm band-pass excitation filter, a 580-nm center wavelength chromatic beam splitter, and a 580-nm long-pass barrier filter) for rhodamine fluorescence.18 The microscope was calibrated by using a uranyl standard. Data, which are expressed in AUs, were stored and processed by the computer.
Lipofuscin Accumulation
Before the cells were stained with Nile red, HMDM
lipofuscin-specific autofluorescence was measured at the
same spectral settings that were used for neutral
lipids.19
Agarose Gel Electrophoresis
The electrophoretic mobility of LDL was determined by using
1.2% agarose gel electrophoresis in 50 mmol/L barbital buffer.
Lipoproteins were visualized by staining with 0.2% Sudan blue in 60%
ethanol.20
Statistics
Significance of differences was calculated by using Student's
t test and ANOVA.
| Results |
|---|
|
|
|---|
Initially the iron contents of media from the experimental groups were
almost the same as from control media. However, 24 hours later there
were significantly increased iron concentrations in the media of most
experimental groups (Table 1
). No exocytosed iron was
detected after the exposure of HMDMs to the higher concentration (50
µg/mL) of Hb, which may be due to cytotoxic effects of Hb.
|
Although it is generally stated that RPMI-1640 does not contain iron, we found a minute concentration (30.73±2.11 µg/L) of iron in fresh, untreated RPMI-1640 (GIBCO, cat No. 041-02404).
The addition of iron or Hb to HMDMs during culture for 24 hours
resulted in only a minor loss of viability as estimated by lactic
dehydrogenase retention and the Trypan Blue dye exclusion test (Table 2
).
|
Superoxide Production
The production of superoxide by HMDMs that were or were
not pre-exposed to iron compounds or Hb and then incubated with LDL in
serum-free medium was determined and compared with control
production. The results, based on SOD-sensitive reduction of
cytochrome c, are shown in Fig 1
. The rates of
cytochrome c reduction in the media of cells pre-exposed to iron or Hb
were somewhat lower than that in control media. The
O2< ARRANGE="STAGGER">-
release by HMDMs (control and
pre-exposed) in the presence of LDL was gradual, with the highest
cumulative value obtained after 8 hours.
|
LDL Oxidation
The TBARS concentrations of the LDL-containing media increased
significantly during the 24 hours of incubation with the HMDMs
pre-exposed to iron or Hb (Fig 2
). No significant
formation of TBARS took place in the absence of LDL. TBARS did not
increase in parallel with the amount of LDL, possibly due to toxic
effects of LDL at high concentrations or a cellular inability to
oxidize more than a certain amount per unit of time (Fig 3
).
|
|
The capacity of media conditioned for 24 hours by HMDM cultures that were or were not pre-exposed to iron or Hb was also studied with respect to the induction of TBARS after the addition of LDL. Media from iron- or Hb-exposed cells induced considerably more TBARS than those of control cells (data not shown).
Agarose Gel Electrophoresis
After 24 hours of incubation with HMDM cultures pre-exposed to
iron compounds or Hb, the mobility of LDL was much increased compared
with native LDL. LDL exposed for 24 hours to conditioned medium from
cells previously exposed to iron or Hb showed increased electrophoretic
mobility (Fig 4
).
|
Lipid Accumulation
When HMDM cultures were pre-exposed for 24 hours to
FeCl3, Fe-ADP, Fe-EDTA, or Hb and then incubated
with LDL in fresh medium without serum for 48 hours, large
accumulations of lipid droplets were apparent in the cells after they
were stained with Nile red. The HMDMs adopted a foam celllike
morphology (Fig 5
), and their content of neutral lipids
and phospholipids increased significantly compared with the controls
(Fig 6
). The accumulation of lipid droplets was enhanced
by increasing the concentrations of LDL.
|
|
Lipofuscin Accumulation
Control HMDMs and HMDMs exposed to FeCl3,
Fe-ADP, or Fe-EDTA (100 µmol/L Fe3+) or Hb (25 or 50
µg/mL) were incubated for 48 hours with LDL. Lipofuscin-specific
autofluorescence was markedly increased in all LDL-exposed
cells, although cultures exposed to iron or Hb showed significantly
higher autofluorescence after LDL incubation than cells
that were not (Fig 7
). A linear correlation was found
between lipofuscin formation and the concentration of FeCl3
to which the HMDMs had been pre-exposed (r=.87,
P=.0054) (Fig 8
).
|
|
| Discussion |
|---|
|
|
|---|
HMDMs were found to continuously produce superoxide anion radicals for a prolonged time when exposed to LDL. The finding of a somewhat decreased production of superoxide by the iron- or Hb-exposed cells compared with unexposed cells may reflect a cellular adaptation mechanism secondary to iron sequestration, as suggested by Olakanmi et al.21 The combined production of superoxide and exocytosis of iron would allow the reduction of the iron from the ferric to the ferrous form with the possibility of further iron-catalyzed oxidative reactions, including Fenton chemistry, that might lead to LDL oxidation.
LDL is modified into a high-uptake form by human monocytes and HMDMs,22 23 24 although its subsequent uptake by macrophages has seldom been reported. The mechanisms behind cell-mediated LDL modification are not entirely clear, but they seem to involve lipid peroxidation. A range of cell types, particularly macrophages/monocytes, are capable of generating superoxide radicals and inducing LDL oxidation in culture; this occurs only in iron-containing media, such as Ham's F10, and not in RPMI-1640, which contains much less iron and copper.1 24 Atherosclerotic lesions sometimes contain detectable iron and copper in a form that promotes lipid peroxidation.7 8 Many researchers, investigating various systems of lipid peroxidation in vitro, have found that the addition of simple iron complexes, which allow iron to act as a redox cycler, is required for lipid peroxidation.25 26 27 Fuhrman et al28 report that iron-induced lipid peroxidation of macrophages increases cell-mediated LDL oxidation and enhances the release of interleukin-1ß and apoE without causing cell death. These findings agree with those of the present study.
Iron bound to EDTA is highly effective in promoting production of hydroxyl radicals by the superoxide-driven Fenton reaction,29 and Sakurai et al30 have reported a direct correlation between iron-ADP concentration and LDL peroxidation. We observed that both of these iron compounds had pronounced effects on LDL oxidation and uptake by HMDMs.
About two thirds of the body iron is within hemoglobin, and hemoglobin concentration may influence cardiovascular disease.31 32 33 Hemoglobin and myoglobin may act as catalysts of the Fenton reaction; these metalloproteins have been described as "frustrated oxidases."34 Rice-Evans and colleagues35 36 37 found that hemoglobin, myoglobin, and ruptured erythrocytes may stimulate oxidation and uptake of LDL by macrophages, and they concluded that iron found in atherosclerotic lesions may be derived from heme proteins released from lysed cells. Our results provide new evidence for this hypothesis.
The presence of lipofuscin (ceroid) pigment in macrophage-derived foam cells is a well-known finding in human atherosclerotic lesions. Extracellular lipoprotein oxidation may be necessary to promote the intracellular appearance of lipofuscin.38 39 We found that LDL and iron both play important roles in macrophage and foam-cell lipofuscinogenesis. To our knowledge, our quantitative data on the relation between lipofuscin accumulation and LDL-HMDM interactions in the presence of iron are the first to have been presented. Our results are also consistent with findings that augmentation of iron in the culture medium of myocytes markedly increases the level of lipofuscin accumulation after iron sequestration in secondary lysosomes.40
In summary, under some conditions HMDMs exocytose iron that may be derived from previously phagocytosed structures rich in metalloproteins, eg, erythrocytes. Such exocytosis may enhance oxidation and uptake of LDL and induce foam cell formation. The present results suggest that iron does play a critical role in atherogenesis. Our experimental model seems to be a suitable system for quantitative and morphological studies of LDL oxidation by human macrophages and the formation of foam cells.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received December 20, 1994; accepted May 9, 1995.
| References |
|---|
|
|
|---|
2. Heinecke JW, Baker L, Rosen H, Chait A. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest. 1986;77:757-761.
3. Hiramatsu K, Rosen H, Heinecke JW, Wolbauer G, Chait A. Superoxide initiates oxidation of low density lipoprotein by human monocytes. Arteriosclerosis. 1987;7:55-60. [Abstract]
4.
Minotti G, Aust SD. The requirement for iron
(III) in the initiation of lipid peroxidation by iron (II) and hydrogen
peroxide. J Biol Chem. 1987;262:1098-1101.
5. Aust SD, Morehouse LA, Thomas CE. Role of metals in oxygen radical reactions. J Free Radic Biol Med. 1985;1:3-7. [Medline] [Order article via Infotrieve]
6. Halliwell B, Gutteridge JMC, Cross CE. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med. 1992;6:598-620.
7. Dubick MA, Hunter GC, Casey SM, Keen CL. Aortic ascorbic acid, trace elements, and superoxide dismutase activity in human aneurysmal and occlusive disease. Proc Soc Exp Biol Med. 1987;184:138-143. [Medline] [Order article via Infotrieve]
8. Smith C, Mitchinson MJ, Aruoma OI, Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J. 1992;286:901-905.
9. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
10. Böyum A. Isolation of lymphocytes, granulocytes, and macrophages. Scand J Immunol Suppl. 1968;8:5-15.
11. Kumagai KK, Hinnuma IS, Tada M. Pretreatment of plastic petri dishes with fetal calf serum: a simple method for macrophage isolation. J Immunol Methods. 1979;67:17-25.
12. Amador E, Dorfman LE, Wacker WEC. Serum lactic dehydrogenase activity: an analytical assessment of current assays. Clin Chem. 1963;8:391-399.
13. Grankvist K, Lernmark Å, Täljedal I-B. Trypan blue as a marker of plasma membrane permeability in alloxan-treated mouse islet cells. J Endocrinol Invest. 1979;2:139-145. [Medline] [Order article via Infotrieve]
14. Allison AC, Harington JS, Birbeck M. An examination of the cytotoxic effect of silica on macrophages. J Exp Med. 1966;124:141-154. [Abstract]
15.
McCord JM, Fridovich I. Superoxide dismutase: an
enzymatic function for erythrocuprein (hemocupreine).
J Biol Chem. 1969;244:6049-6055.
16. Massey V. The microestimation of succinate and the extinction coefficient of cytochrome c. Biochim Biophys Acta. 1959;34:255-257. [Medline] [Order article via Infotrieve]
17. Buege J, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302-310. [Medline] [Order article via Infotrieve]
18. Koren E, Franzen J, Fugate RD, Alaupovic P. Analysis of cholesterol ester accumulation in macrophages by the use of digital imaging fluorescence microscopy. Atherosclerosis. 1990;38:175-184.
19. Sohal R, Marzabadi MR, Galaris D, Brunk UT. Effect of ambient oxygen concentration on lipofuscin accumulation in cultured rat heart myocytes: a novel in vitro model of lipofuscinogenesis. J Free Radic Biol Med. 1989;6:23-30.
20. Nobel RP. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res. 1968;9:693-700. [Abstract]
21. Olakanmi O, McGowan SE, Hayek MB, Britigan BE. Iron sequestration by macrophages decreases the potential for extracellular hydroxyl radical formation. J Clin Invest. 1993;91:889-899.
22. Cathcart MK, Morel DW, Chisolm GM. Monocytes and neutrophils oxidized low density lipoprotein making it cytotoxic. J Leukoc Biol. 1985;38:341-350. [Abstract]
23. Cathcart MK, Chisolm GM, McNally AK, Morel DW. Oxidative modification of low density lipoprotein (LDL) by activated human monocytes and the cell lines U937 and HL60. In Vitro Cell Dev Biol. 1988;24:1001-1008. [Medline] [Order article via Infotrieve]
24. Cathcart MK, McNally AK, Morel W, Chisolm GM III. Superoxide anion participation in human monocyte-mediated oxidation of low density lipoprotein and conversion of low density lipoprotein to a cytotoxin. J Immunol. 1989;142:1963-1969. [Abstract]
25. Panasenko OM, Volnov TV, Osipova AN, Azizova OA. Free-radical generation by monocytes and neutrophils: a possible cause of plasma lipoprotein modification. Biomed Sci. 1991;2:581-589. [Medline] [Order article via Infotrieve]
26. Borg DC, Schaich KM. Iron and hydroxyl radicals in lipid oxidation: Fenton reactions in lipid and nucleic acids co-oxidized with lipid. In: Cerutti PA, Fridovich I, McCord JM, eds. Oxy-Radicals in Molecular Biology and Pathology. New York, NY: Alan R. Liss, Inc; 1988:427-441.
27. Schaich KM. Metals and lipid oxidation: contemporary issues. Lipids. 1992;27:209-218. [Medline] [Order article via Infotrieve]
28. Fuhrman B, Oiknine J, Aviram M. Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties. Atherosclerosis. 1994;111:65-78.[Medline] [Order article via Infotrieve]
29. Smith JB, Cusumano JC, Bobbs CF. Quantitative effects of iron chelators on hydroxyl radical production by the superoxide-driven Fenton reaction. Free Radic Res Commun. 1990;8:101-108. [Medline] [Order article via Infotrieve]
30. Sakurai T, Satsuki K, Minorun N, Hirokazu K. Oxidative modification of glycated low density lipoprotein in the presence of iron. Biochem Biophys Res Commun. 1991;177:433-439. [Medline] [Order article via Infotrieve]
31. Shimakawa T, Bild DE. Relationship between haemoglobin and cardiovascular risk factors in young adults. J Clin Epidemiol. 1993;46:1257-1266. [Medline] [Order article via Infotrieve]
32. Carlson LA, Böttiger LE, Åhfeldt PE. Risk factors for myocardial infarction in the Stockholm prospective study. Acta Med Scand. 1979;206:351-360.[Medline] [Order article via Infotrieve]
33.
Balla G, Jacob HS, Eaton JW, Belcher JD, Vercellotti
GM. Hemin: a possible physiological mediator
of low-density lipoprotein oxidation and endothelial
injury. Arterioscler Thromb. 1991;11:1700-1711.
34. Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990;186:1-85. [Medline] [Order article via Infotrieve]
35. Rice-Evans C, Green E, Paganga G, Cooper C, Wrigglesworth J. Oxidised low density lipoproteins induce iron release from activated myoglobin. FEBS Lett. 1993;326:177-182. [Medline] [Order article via Infotrieve]
36. Paganga G, Rice-Evans C, Andrews B, Leake D. Oxidised low density lipoproteins convert oxyhaemoglobin from ruptured erythrocytes to reactive ferryl forms. Biochem Soc Trans. 1992;20:331S. [Medline] [Order article via Infotrieve]
37. Paganga G, Rice-Evans C, Rule R, Leake D. The interaction between ruptured erythrocytes and low-density lipoproteins. FEBS Lett. 1992;303:154-158. [Medline] [Order article via Infotrieve]
38. Ball RY, Bindman JP, Carpenter KLH, Mitchinson MJ. Oxidized low density lipoprotein induces ceroid accumulation by murine peritoneal macrophages in vitro. Atherosclerosis. 1986;60:173-181. [Medline] [Order article via Infotrieve]
39. Mitchinson MJ, Ball RY, Carpenter KLH, Enright JH. Macrophages and ceroid in human atherosclerosis. Eur Heart J. 1990;11(suppl E):116-121.
40. Marzabadi MR, Sohal RS, Brunk UT. Effect of ferric iron and desferrioxamine on lipofuscin accumulation in cultured rat heart myocytes. Mech Ageing Dev. 1988;46:145-157.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
K. Yunoki, T. Naruko, R. Komatsu, S. Ehara, N. Shirai, K. Sugioka, M. Nakagawa, C. Kitabayashi, Y. Ikura, A. Itoh, et al. Enhanced expression of haemoglobin scavenger receptor in accumulated macrophages of culprit lesions in acute coronary syndromes Eur. Heart J., August 1, 2009; 30(15): 1844 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Schrijvers, G. R.Y. De Meyer, A. G. Herman, and W. Martinet Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability Cardiovasc Res, February 1, 2007; 73(3): 470 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, M. Ostblom, L.-H. Xu, A. Hellsten, P. Leanderson, B. Liedberg, U. T. Brunk, J. W. Eaton, and X.-M. Yuan Cytocidal effects of atheromatous plaque components: the death zone revisited FASEB J, November 1, 2006; 20(13): 2281 - 2290. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wolff, H. Volzke, J. Ludemann, D. Robinson, D. Vogelgesang, A. Staudt, C. Kessler, J. B. Dahm, U. John, and S. B. Felix Association Between High Serum Ferritin Levels and Carotid Atherosclerosis in the Study of Health in Pomerania (SHIP) Stroke, February 1, 2004; 35(2): 453 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Kolodgie, H. K. Gold, A. P. Burke, D. R. Fowler, H. S. Kruth, D. K. Weber, A. Farb, L.J. Guerrero, M. Hayase, R. Kutys, et al. Intraplaque Hemorrhage and Progression of Coronary Atheroma N. Engl. J. Med., December 11, 2003; 349(24): 2316 - 2325. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L Derstine, L. E Murray-Kolb, S. Yu-Poth, R. L Hargrove, P. M Kris-Etherton, and J. L Beard Iron status in association with cardiovascular disease risk in 3 controlled feeding studies Am. J. Clinical Nutrition, January 1, 2003; 77(1): 56 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rossi, B. M. McQuillan, J. Hung, P. L. Thompson, C. Kuek, and J. P. Beilby Serum Ferritin and C282Y Mutation of the Hemochromatosis Gene as Predictors of Asymptomatic Carotid Atherosclerosis in a Community Population Stroke, December 1, 2000; 31(12): 3015 - 3020. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M Cromheeke, M. M Kockx, G. R.Y De Meyer, J. M Bosmans, H. Bult, W. J.F Beelaerts, C. J Vrints, and A. G Herman Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques Cardiovasc Res, August 15, 1999; 43(3): 744 - 754. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. de Valk and J. J. M. Marx Iron, Atherosclerosis, and Ischemic Heart Disease Arch Intern Med, July 26, 1999; 159(14): 1542 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-S. Lee, M.-S. Shiao, C.-C. Pan, and L.-Y. Chau Iron-Deficient Diet Reduces Atherosclerotic Lesions in ApoE-Deficient Mice Circulation, March 9, 1999; 99(9): 1222 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Camejo, C. Halberg, A. Manschik-Lundin, E. Hurt-Camejo, B. Rosengren, H. Olsson, G. I. Hansson, G.-B. Forsberg, and B. Ylhen Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages J. Lipid Res., April 1, 1998; 39(4): 755 - 766. [Abstract] [Full Text] |
||||
![]() |
S. Kiechl, J. Willeit, G. Egger, W. Poewe, F. Oberhollenzer, and f. t. B. S. Group Body Iron Stores and the Risk of Carotid Atherosclerosis : Prospective Results From the Bruneck Study Circulation, November 18, 1997; 96(10): 3300 - 3307. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |